NASDAQ : FEMY
Femasys Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 1.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.06M |
| Enterprise Value | 14.40M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 8.38M |
| Shares Outstanding | 8.38M |
| Shares Change (YoY) | +140.02% |
| Shares Change (QoQ) | -14.03% |
| Owned by Insiders (%) | 3.22% |
| Owned by Institutions (%) | 31.34% |
| Float | 6.88M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.99 |
| Forward PS | 2.24 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 2.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 6.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.14 |
| Quick Ratio | 0.41 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.48 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -424.97% |
| Return on Assets (ROA) | -84.22% |
| Return on Invested Capital (ROIC) | -120.77% |
| Return on Capital Employed (ROCE) | -209.05% |
| Weighted Average Cost of Capital (WACC) | 0.97% |
| Revenue Per Employee | $42,583 |
| Profits Per Employee | -$217,928 |
| Employee Count | 54 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.16 |
Taxes
| Measure | Value |
|---|
| Income Tax | 6,350 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -2.15 |
| 52-Week Price Change | -89.64% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 6.08 |
| Relative Strength Index (RSI) | 26.24 |
| Average Volume (20 Days) | 99,685 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 164,106 |
| Short Previous Month | 577,249 |
| Short % of Shares Out | 1.96% |
| Short % of Float | 2.39% |
| Short Ratio (days to cover) | 1.70 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.30M |
| Gross Profit | 1.40M |
| Operating Income | -17.57M |
| Pretax Income | -11.76M |
| Net Income | -11.77M |
| EBITDA | -17.23M |
| EBIT | -17.57M |
| Loss Per Share | -$3.96 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.44M |
| Total Debt | 4.79M |
| Net Cash | -3.35M |
| Net Cash Per Share | -$0.40 |
| Equity (Book Value) | 4.03M |
| Book Value Per Share | 1.33 |
| Working Capital | 4.45M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -17.65M |
| Capital Expenditures | -422,713 |
| Depreciation & Amortization | 335,977 |
| Net Borrowing | 4.87M |
| Free Cash Flow | -18.07M |
| FCF Per Share | -$2.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.95% |
| Operating Margin | -763.90% |
| Pretax Margin | -511.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -140.02% |
| Shareholder Yield | -140.02% |
| Earnings Yield | -299.75% |
| FCF Yield | -157.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.50 |
| Price Target Difference | 1,150.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 105.22% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 8, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -19.01 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |